CAH
Price
$161.02
Change
-$0.67 (-0.41%)
Updated
Jul 15 closing price
Capitalization
27.26B
22 days until earnings call
OMI
Price
$7.93
Change
+$0.16 (+2.06%)
Updated
Jul 16 closing price
Capitalization
2.11B
15 days until earnings call
Interact to see
Advertisement

CAH vs OMI

Header iconCAH vs OMI Comparison
Open Charts CAH vs OMIBanner chart's image
Cardinal Health
Price$161.02
Change-$0.67 (-0.41%)
Volume$1.92M
Capitalization27.26B
Owens & Minor
Price$7.93
Change+$0.16 (+2.06%)
Volume$652.07K
Capitalization2.11B
CAH vs OMI Comparison Chart in %
Loading...
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAH vs. OMI commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAH is a StrongBuy and OMI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (CAH: $161.11 vs. OMI: $7.93)
Brand notoriety: CAH and OMI are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: CAH: 66% vs. OMI: 52%
Market capitalization -- CAH: $27.26B vs. OMI: $2.11B
CAH [@Medical Distributors] is valued at $27.26B. OMI’s [@Medical Distributors] market capitalization is $2.11B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAH’s FA Score shows that 2 FA rating(s) are green whileOMI’s FA Score has 1 green FA rating(s).

  • CAH’s FA Score: 2 green, 3 red.
  • OMI’s FA Score: 1 green, 4 red.
According to our system of comparison, CAH is a better buy in the long-term than OMI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAH’s TA Score shows that 3 TA indicator(s) are bullish while OMI’s TA Score has 4 bullish TA indicator(s).

  • CAH’s TA Score: 3 bullish, 5 bearish.
  • OMI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CAH is a better buy in the short-term than OMI.

Price Growth

CAH (@Medical Distributors) experienced а -1.92% price change this week, while OMI (@Medical Distributors) price change was -8.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.26%. For the same industry, the average monthly price growth was +6.97%, and the average quarterly price growth was +1.23%.

Reported Earning Dates

CAH is expected to report earnings on Oct 31, 2025.

OMI is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Distributors (+0.26% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAH($27.3B) has a higher market cap than OMI($2.11B). OMI has higher P/E ratio than CAH: OMI (64.10) vs CAH (44.47). CAH YTD gains are higher at: 37.653 vs. OMI (-39.327). CAH has higher annual earnings (EBITDA): 1.89B vs. OMI (391M). CAH has more cash in the bank: 4.59B vs. OMI (243M). OMI has less debt than CAH: OMI (2.32B) vs CAH (4.72B). CAH has higher revenues than OMI: CAH (216B) vs OMI (10.3B).
CAHOMICAH / OMI
Capitalization27.3B2.11B1,296%
EBITDA1.89B391M484%
Gain YTD37.653-39.327-96%
P/E Ratio44.4764.1069%
Revenue216B10.3B2,097%
Total Cash4.59B243M1,889%
Total Debt4.72B2.32B204%
FUNDAMENTALS RATINGS
CAH vs OMI: Fundamental Ratings
CAH
OMI
OUTLOOK RATING
1..100
7563
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
297
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
964
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CAH's Valuation (50) in the Medical Distributors industry is in the same range as OMI (59). This means that CAH’s stock grew similarly to OMI’s over the last 12 months.

CAH's Profit vs Risk Rating (2) in the Medical Distributors industry is significantly better than the same rating for OMI (97). This means that CAH’s stock grew significantly faster than OMI’s over the last 12 months.

OMI's SMR Rating (97) in the Medical Distributors industry is in the same range as CAH (100). This means that OMI’s stock grew similarly to CAH’s over the last 12 months.

CAH's Price Growth Rating (9) in the Medical Distributors industry is somewhat better than the same rating for OMI (64). This means that CAH’s stock grew somewhat faster than OMI’s over the last 12 months.

OMI's P/E Growth Rating (2) in the Medical Distributors industry is significantly better than the same rating for CAH (100). This means that OMI’s stock grew significantly faster than CAH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAHOMI
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
45%
Bearish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 20 days ago
67%
Bullish Trend 16 days ago
73%
Declines
ODDS (%)
Bearish Trend 6 days ago
46%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
CAH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OMI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLCAX14.41N/A
N/A
Allspring Large Company Value A
FBSRX36.25N/A
N/A
Franklin Mutual U.S. Mid Cap Value R
MWEBX40.58N/A
N/A
MFS Global Equity B
MIGNX45.88N/A
N/A
MFS Massachusetts Inv Gr Stk R6
JDDVX12.57N/A
N/A
Janus Henderson U.S. Dividend Income D